Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

HOOD Stock Spikes on Robinhood Crypto Wallet News. 7 Things to Know.

Today, popular brokerage Robinhood has announced plans to launch a crypto wallet, sending shares of HOOD stock 5% higher in early trading.

ONTX Stock Is Soaring 25% on This Big Cancer Drug Update

Today, Oncova Therapeutics announced some positive preliminary trial results from one of its core cancer drugs, sending ONTX stock higher.

DVAX Stock: What Is the Covid-19 News Lifting Dynavax Today?

Today, some impressive vaccine-related news has sent Dynavax and shares of DVAX stock significantly higher as investors pile in.

7 Cannabis Stocks Ready to Light up the Market This Fall

Investors looking for top-notch cannabis stocks ought to check out these seven companies, each of which has impressive upside potential.

7 Crypto Stocks to Buy to Honor Bitcoin’s New Legal Tender Status

These top crypto stocks are among the premier options for investors looking at ways to play the surging cryptocurrency space.